Researcher.Life Logo

ClinicoEconomics and Outcomes Research : Impact Factor & More

eISSN: 1178-6981pISSN: 1178-6981
JournalOpen Access

Key Metrics

CiteScore
2.5
SJR
Q2Health Policy
SNIP
0.74
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on ClinicoEconomics and Outcomes Research

ClinicoEconomics and Outcomes Research Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher DOVE MEDICAL PRESS LTD
Language English
Frequency Continuous publication
Article Processing ChargesUSD 2390
Publication Time16
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2009
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 16
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC BY-NC
OA statementVisit website
View less

Planning to publish in ClinicoEconomics and Outcomes Research ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in ClinicoEconomics and Outcomes Research

Cost-Effectiveness of Blinatumomab Plus Chemotherapy vs Chemotherapy in Adults Newly Diagnosed with Philadelphia-Negative B-Cell Acute Lymphoblastic Leukemia in Italy
  • 12 Jun 2026
  • ClinicoEconomics and Outcomes Research: CEOR
The Cost-Effectiveness and Budget Impact Analysis of Upadacitinib for Moderate-to-Severe Atopic Dermatitis in Saudi Arabia
  • 11 Jun 2026
  • ClinicoEconomics and Outcomes Research: CEOR
Real-World Clinical and Economic Outcomes Among Patients with Localized Prostate Cancer Undergoing Radical Prostatectomy Across Different Risk Stratifications in the United States
  • 27 May 2026
  • ClinicoEconomics and Outcomes Research: CEOR
Cancer Medication Consumptions in Vietnam Between 2019 and 2023: An Analysis from the National Database
  • 27 May 2026
  • ClinicoEconomics and Outcomes Research: CEOR
Model-Based Cost-Effectiveness Analysis of Routine Omega-3 Testing and Targeted Supplementation to Reduce Early Preterm Birth in Australia Compared with Current Practice
  • 26 May 2026
  • ClinicoEconomics and Outcomes Research: CEOR
The Socioeconomic Impact of Long-Acting Injectable Buprenorphine
  • 20 May 2026
  • ClinicoEconomics and Outcomes Research: CEOR
Cost-Effectiveness of Blinatumomab Plus Chemotherapy vs Chemotherapy in Adults Newly Diagnosed with Philadelphia-Negative B-Cell Acute Lymphoblastic Leukemia in Italy
  • 12 Jun 2026
  • ClinicoEconomics and Outcomes Research: CEOR
The Cost-Effectiveness and Budget Impact Analysis of Upadacitinib for Moderate-to-Severe Atopic Dermatitis in Saudi Arabia
  • 11 Jun 2026
  • ClinicoEconomics and Outcomes Research: CEOR
Real-World Clinical and Economic Outcomes Among Patients with Localized Prostate Cancer Undergoing Radical Prostatectomy Across Different Risk Stratifications in the United States
  • 27 May 2026
  • ClinicoEconomics and Outcomes Research: CEOR
Cancer Medication Consumptions in Vietnam Between 2019 and 2023: An Analysis from the National Database
  • 27 May 2026
  • ClinicoEconomics and Outcomes Research: CEOR
Model-Based Cost-Effectiveness Analysis of Routine Omega-3 Testing and Targeted Supplementation to Reduce Early Preterm Birth in Australia Compared with Current Practice
  • 26 May 2026
  • ClinicoEconomics and Outcomes Research: CEOR
The Socioeconomic Impact of Long-Acting Injectable Buprenorphine
  • 20 May 2026
  • ClinicoEconomics and Outcomes Research: CEOR

FAQs on ClinicoEconomics and Outcomes Research